Guidance for Industry on Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment; Availability; Correction

---
identifier: "/us/fr/2012-14485"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Guidance for Industry on Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment; Availability; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2012-14485"
section_name: "Guidance for Industry on Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment; Availability; Correction"
positive_law: false
currency: "2012-06-14"
last_updated: "2012-06-14"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-14485"
document_type: "notice"
publication_date: "2012-06-14"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "77 FR 35689"
fr_volume: 77
docket_ids:
  - "Docket No. FDA-2010-D-0146"
fr_action: "Notice; correction."
---


#  Guidance for Industry on Irritable Bowel Syndrome—Clinical Evaluation of Drugs for Treatment; Availability; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of May 31, 2012 (77 FR 32124). The document announced the availability of a guidance for industry entitled “Irritable Bowel Syndrome—Clinical Evaluation of Drugs for Treatment.” The document was published with an incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 2012-13143, appearing on page 32124 in the *Federal Register* of Thursday, May 31, 2012, the following correction is made:

1. On page 32124, in the first column, in the headings section of the document, “[Docket No. FDA-2012-D-0146]” is corrected to read “[Docket No. FDA-2010-D-0146]”.

Dated: June 8, 2012.

Leslie Kux,

Assistant Commissioner for Policy.